Dalpiciclib plus endocrine therapy in women with HR(+)/HER2(-) advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial. (nature.com)

Authors: Mo H … Ma F Journal: Nature Cancer Published: 2026-07-21 DOI: https://doi.org/10.1038/s43018-026-01208-0